| HOME >> BIOLOGY >> TECHNOLOGY |
on short-term investments (29) (177)
Change in valuation of warrants (89) -
Other 1 36
Changes in operating assets and
liabilities:
Other assets (163) (420)
Accounts payable and
accrued liabilities (315) (1,178)
Deferred rent 181 466
Net cash used in operating activities (8,699) (10,091)
Investing activities:
Purchases of property and equipment (187) (3,990)
Purchases of short-term investments (468) (6,263)
Maturities of short-term investments 500 14,900
Restricted cash (120) -
Net cash provided by (used in)
investing activities (275) 4,647
Financing activities:
Proceeds from debt - 4,362
Payments on debt (1,476) (1,186)
Issuance of common stock and warrants 177 10,207
Net cash provided by (used in)
financing activities (1,299) 13,383
Net increase (decrease) in cash
and cash equivalents (10,273) 7,939
Cash and cash equivalents at
beginning of period 26,362 14,249
Cash and cash equivalents at
end of period $ 16,089 $ 22,188
Supplemental non-cash activities:
Capitalized interest recorded as
property, plant and equipment $ 63 $
'/>"/>
| SOURCE Favrille, Inc. Copyright©2008 PR Newswire. All rights reserved |